latest news in Cannabinoid Regulation

Medicare Expands Hemp Incentives but Doctors Demand Clear Clinical Proof

Medicare Expands Hemp Incentives but Doctors Demand Clear Clinical Proof

Washington, Saturday, 12 September 2026.
Despite Medicare offering incentives for hemp-derived treatments, doctors remain reluctant to recommend them without standardized clinical trials, highlighting a critical gap between policy and physician adoption.